← Oncology Approval Tracker

FDA DECISION ·

Nelarabine (generic Arranon)

nelarabine · Zydus Pharmaceuticals

First generic approvalFirst genericT-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic nelarabine injection for adults and children age 1 and older with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma after at least two failed chemotherapy regimens.

LAMPGEN ANALYSIS

Why it matters

The approval covers the same later-line T-cell leukemia and lymphoma populations as the reference drug.

What research teams should watch

Track prior regimen count and neurologic baseline assessments and verify vial concentration at preparation.

PRIMARY RECORDS

Sources